ROR1

ROR1

ROR1 Overview

Molecule Name
Inactive tyrosine-protein kinase transmembrane receptor ROR1
Synonyms
ROR1,NTRKR1
Drug Development Progress
Drugs in Clinical Trials23
Approved Drugs0
Highest Development StagePhase 3 Clinical
Target Synonym
EC 2.7.10.1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,NTRKR1,ROR1,Receptor Tyrosine Kinase Like Orphan Receptor 1,Neurotrophic Tyrosine Kinase, Receptor-Related 1,DJ537F10.1,ROR-1
Background
Tyrosine-protein kinase transmembrane receptor ROR1 is also known as Neurotrophic tyrosine kinase, receptor-related 1 (NTRKR1), which belongs to the protein kinase superfamily or tyr protein kinase family or ROR subfamily. ROR1 contains 1 FZ (frizzled) domain, 1 Ig-like C2-type (immunoglobulin-like) domain, 1 kringle domain, 1 protein kinase domain. ROR1 is expressed at high levels during early embryonic development. The expression levels drop strongly around day 16 and there are only very low levels in adult tissues. Isoform Short is strongly expressed in fetal and adult CNS and in a variety of human cancers, including those originating from CNS or PNS neuroectoderm. ROR1 could interact with casein kinase 1 epsilon (CK1ε) to activate phosphoinositide 3-kinase-mediated AKT phosphorylation and cAMP-response-element-binding protein (CREB), which was associated with enhanced tumor-cell growth.

ROR1 Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Antibody Project Trading Platform

Project NameProject StageMolecule TypeMolecule SourceDisease AreaIndication
ROR1 mAb - 01LeadMonoclonalFull HumanHematological Malignancy,AutoImmunitySolid tumor,Blood tumor
Project Name
ROR1 mAb - 01
Project Stage
Lead
Molecule Type
Monoclonal
Molecule Source
Full Human
Disease Area
Hematological Malignancy,AutoImmunity
Indication
Solid tumor,Blood tumor